71: Early experience with osimertinib as second line treatment for EGFR mutated non-small cell lung cancer (NSCLC) and detecting T790M mutations from plasma circulating tumour DNA (ctDNA). (January 2017)

Record Type:: Journal Article
Title:: 71: Early experience with osimertinib as second line treatment for EGFR mutated non-small cell lung cancer (NSCLC) and detecting T790M mutations from plasma circulating tumour DNA (ctDNA). (January 2017)
Main Title:: 71: Early experience with osimertinib as second line treatment for EGFR mutated non-small cell lung cancer (NSCLC) and detecting T790M mutations from plasma circulating tumour DNA (ctDNA)
Authors:: Lewis, P.J.
Cox, R.A.
Abstract:
Is Part Of:: Lung cancer. Volume 103(2017)Supplement 1
Journal:: Lung cancer
Issue:: Volume 103(2017)Supplement 1
Issue Display:: Volume 103, Issue 2017 (2017)
Year:: 2017
Volume:: 103
Issue:: 2017
Issue Sort Value:: 2017-0103-2017-0000
Page Start:: S34
Page End:
Publication Date:: 2017-01
Subjects:: Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:: http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0169-5002(17)30121-6 ↗
Languages:: English
ISSNs:: 0169-5002
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 1560.xml